Hanna L M Rajala (Hanna Rajala)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Regulatory T Cells

High Throughput Sequencing

Top Venues

Science advances

Nature communications

Case reports in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Sofie A Lundgren, Mikko Myllymäki, Timo Järvinen, Mikko A I Keränen, Jason Theodoropoulos, Johannes Smolander, Daehong Kim, Urpu Salmenniemi, Gunilla Walldin, Paula Savola, Tiina Kelkka, Hanna L M Rajala, Eva Hellström Lindberg, Maija Itälä-Remes, Matti Kankainen, Mohamed El Missiry
Somatic mutations associate with clonal expansion of CD8 + T cells. Science advances 10 (23) (2024)
Sofie A Lundgren, Mikko Myllymäki, Timo Järvinen, Mikko A I Keränen, Jason Theodoropoulos, Johannes Smolander, Daehong Kim, Urpu Salmenniemi, Gunilla Walldin, Paula Savola, Tiina Kelkka, Hanna L M Rajala, Eva Hellström Lindberg, Maija Itälä-Remes, Matti Kankainen, Mohamed El Missiry
Somatic mutations associate with clonal expansion of CD8 + T cells. Science advances 10 (23) (2024)
Jani Huuhtanen, Dipabarna Bhattacharya, Tapio Lönnberg, Matti Kankainen, Cassandra Kerr, Jason Theodoropoulos, Hanna L M Rajala, Carmelo Gurnari, Tiina Kasanen, Till Braun, Antonella Teramo, Renato Zambello, Marco Herling, Fumihiro Kawakami, Toru Kawakami, Marko Salmi, Thomas Loughran, Jaroslaw P Maciejewski, Harri Lähdesmäki, Tiina Kelkka, Mohamed El Missiry
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8 + T-cell large granular lymphocytic leukemia. Nature communications 13 (1) (2022)
Hanna L M Rajala, Veli-Jukka Anttila, Mikko Haapio, Mikko A I Keränen, Ulla Wartiovaara-Kautto, Riikka Räty
Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases. Case reports in hematology 2021 (2021)